Japanese Infrastructure Stock News

The market for Medical System Network Co., Ltd.'s ( TSE:4350 ) shares didn't move much after it posted weak earnings...

Shareholders appeared unconcerned with JFE Holdings, Inc.'s ( TSE:5411 ) lackluster earnings report last week. We did...

The subdued market reaction suggests that Relo Group, Inc.'s ( TSE:8876 ) recent earnings didn't contain any surprises...

After announcing healthy earnings, Koei Tecmo Holdings Co., Ltd.'s ( TSE:3635 ) stock rose over the last week. Despite...

Teijin (TSE:3401) has attracted fresh attention after a recent share price move, with the stock last closing at ¥1,639.5. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for Teijin. Recent trading has built on Teijin’s positive year to date momentum, with a 1 day share price return of 0.52% and a 7 day share price return of 2.82%. This has contributed to a 22.21% year to date share price return and a 45.18% total...

KOA Corporation ( TSE:6999 ) just reported some strong earnings, and the market reacted accordingly with a healthy...

The recent earnings posted by Sato Shoji Corporation ( TSE:8065 ) were solid, but the stock didn't move as much as we...

Despite posting some strong earnings, the market for Tokyu Construction Co., Ltd.'s ( TSE:1720 ) stock hasn't moved...

Despite posting some strong earnings, the market for Takara Standard Co.,Ltd.'s ( TSE:7981 ) stock hasn't moved much...

Shareholders might have noticed that Nippon Steel Corporation ( TSE:5401 ) filed its yearly result this time last week...

Oracle Corporation Japan (TSE:4716) has just closed out FY 2026 with fourth quarter revenue of ¥78.4 billion and basic EPS of ¥129.59, alongside net income excluding extraordinary items of ¥16,608 million. Over recent quarters the company has seen revenue move from ¥70.6 billion in Q4 FY 2025 to ¥78.4 billion in Q4 FY 2026, with quarterly basic EPS shifting from ¥123.96 to ¥129.59 over the same period. This provides a clearer view of how the top and bottom line are tracking into the new year...

Advantest (TSE:6857) just closed FY 2026 with fourth quarter revenue of ¥328,073 million and basic EPS of ¥174.81, capping off a year in which trailing twelve month revenue reached about ¥1.1 trillion and EPS came in at ¥515.15. Over the past six reported quarters, the company has seen quarterly revenue move from ¥218,200 million in FY 2025 Q3 to ¥328,073 million in FY 2026 Q4, while basic EPS shifted from ¥70.31 to ¥174.81. Trailing twelve month net income of ¥375,353 million contributed to...

Chainlink has enabled onchain access to Toyota Motor's TSE:7203 share data through its APAC Equities Streams. The launch brings real-time, onchain trading data for major Japanese companies, including Toyota Motor. This update connects Toyota's equity data to decentralized finance applications that use high frequency market feeds. Toyota Motor, listed as TSE:7203, is best known for its global automotive operations, but this latest move links the stock more directly with emerging blockchain...

HeiwadoLtd (TSE:8276) opened its 2027 financial year with Q1 revenue of ¥112.2b and basic EPS of ¥23.98, alongside net income excluding extra items of ¥1,186m, setting a measured tone for the new fiscal period. The company has seen quarterly revenue move from ¥108.5b in Q1 2026 to ¥112.2b in Q1 2027, with basic EPS shifting from ¥43.21 to ¥23.98 over the same timeframe, giving investors a clear read on how the top and bottom lines are tracking year over year. With net profit margin recently...

Zuiko (TSE:6279) opened its new fiscal year with Q1 2027 revenue of ¥4,170 million and a Basic EPS loss of ¥6.97, while trailing 12 month EPS stood at ¥69.56 on revenue of ¥20.18 billion, reflecting the impact of a ¥1.7 billion one off gain on reported profitability. Over recent quarters the company has seen revenue move from ¥6,017.90 million in Q4 2025 to ¥5,164.55 million in Q1 2026, then to ¥5,328.45 million, ¥5,444.33 million and ¥5,232.68 million through 2026, with EPS shifting from a...

Ichibanya (TSE:7630) opened Q1 2027 with revenue of ¥16,976 million and net income of ¥728 million, translating into basic EPS of ¥4.56 and setting the tone for how investors assess its current profitability. Over recent periods, the company has seen revenue move from ¥15,750 million in Q1 2026 to ¥16,976 million in Q1 2027, while basic EPS shifted from ¥5.78 to ¥4.56 alongside trailing twelve month EPS of ¥14.84 on revenue of ¥66,744 million. With a trailing net margin of 3.5% versus 5.2%...

DCM Holdings (TSE:3050) opened Q1 2027 with revenue of ¥151.9 billion and basic EPS of ¥47.74, setting the tone for a results season where investors are already watching how modest earnings growth trends feed into the story. The company has seen quarterly revenue move from ¥138.3 billion in Q1 2026 to ¥151.9 billion in Q1 2027, with basic EPS over the same period shifting from ¥43.89 to ¥47.74. Trailing 12 month basic EPS of ¥131.17 and net income of ¥17.99 billion anchor the broader picture...

Okuwa (TSE:8217) opened Q1 2027 with revenue of ¥59.7 billion and a net loss of ¥268 million, translating to basic EPS of ¥6.59 loss as investors weigh how this quarter fits into the recent return to modest profitability on a trailing basis. The company has seen quarterly revenue move between ¥59.7 billion and ¥66.4 billion over the last six reported periods, while basic EPS has swung from a ¥54.33 loss to a ¥5.91 profit, highlighting how sensitive the bottom line has been to one off items...

Nissan Motor (TSE:7201) continues to draw attention as the stock trades around ¥300, following a period of weaker returns over the past month and past 3 months that has tested investor sentiment. See our latest analysis for Nissan Motor. Viewed over a longer stretch, Nissan Motor’s recent slide has been more than a short term wobble, with the share price down 24.81% over 30 days and year to date share price return down 23.61%. The 1 year total shareholder return is down 14.70% and the 3 year...

SMS stock moves after recent performance data SMS (TSE:2175) has drawn attention after recent share price performance data, prompting investors to look more closely at how its aging society focused information infrastructure business and current financial profile fit into their portfolios. See our latest analysis for SMS. The recent 1 day share price return of 1.79% and year to date share price return of 55.93% suggest momentum has been building, even though the 5 year total shareholder...

Global markets are wrestling with mixed signals, from firm US consumer spending and persistent inflation readings to ongoing policy support and industrial strength in China. In this setting, many investors are looking past short term headlines and focusing on companies where analysts see healthy earnings growth potential and balance sheets that can handle bumps along the way. This is exactly what the Healthy high growth potential screener targets. It highlights stocks that combine expected...

Income investors are facing a mixed picture, with inflation signals, interest rate expectations and global trade all moving at different speeds. In this kind of cross current, many readers are looking for clearer, more predictable cash flows from their portfolios. That is where high quality dividend stocks can help. The Dividend Powerhouses screener focuses on companies with more than a 5% yield that appears well covered, growing and stable, so you are not just chasing high payouts for the...

Board meeting decision links pay to performance and sustainability Hokuhoku Financial Group (TSE:8377) has approved the disposal of 17,945 treasury shares to fund a performance linked stock compensation plan for directors and executives, tying pay to financial and sustainability indicators. See our latest analysis for Hokuhoku Financial Group. Hokuhoku Financial Group shares have gained momentum recently, with a 7 day share price return of 4.49% and a year to date share price return of...

Why Shionogi stock is back on infectious disease investors’ radar Shionogi (TSE:4507) has drawn fresh attention after Japan approved a pediatric regimen for its COVID-19 drug XOCOVA, and partner F2G reported positive Phase 3 OASIS results for olorofim, supporting progress in infectious disease treatments. See our latest analysis for Shionogi. Despite the steady stream of infectious disease updates, Shionogi’s short term share price performance has been weak. It has a 30 day share price return...